Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6115)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Krastev Z, Jelev D, Antonov K, Petkova T, Atanasova E, Zheleva N, Tomov B, Boyanova Y, Mateva L. Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma. World J Gastroenterol 2016; 22(8): 2630-2635 [PMID: 26937151 DOI: 10.3748/wjg.v22.i8.2630] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i8/2630.htm |
| Number | Citing Articles |
| 1 |
Anna Szymanek-Pasternak, Karolina Rostkowska, Krzysztof Simon. Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation. BMJ Case Reports 2017; : bcr-2017-220152 doi: 10.1136/bcr-2017-220152
|
| 2 |
|
| 3 |
Vinicius Lins Ferreira, Leticia Paula Leonart, Ana Maria Della Rocca, Roberto Pontarolo. Analysis of Safety Outcomes in Chronic Hepatitis C Patients using Interferon-free Treatment: A Systematic Review of Case Reports. Current Drug Therapy 2019; 14(3): 210 doi: 10.2174/1574885514666190130162547
|
| 4 |
Carmen M. Preda, Corneliu P. Popescu, Cristian Baicus, Theodor A. Voiosu, Mircea Manuc, Corina Silvia Pop, Liana Gheorghe, Ioan Sporea, Anca Trifan, Marcel Tantau, Alina Tantau, Emanoil Ceausu, Doina Proca, Ileana Constantinescu, Simona M. Ruta, Mircea M. Diculescu, Alexandru Oproiu. Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis. Liver International 2018; 38(4): 602 doi: 10.1111/liv.13550
|
| 5 |
C. Weil, D. Mehta, G. Koren, B. Pinsky, J. C. Samp, G. Chodick, V. Shalev. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider. Journal of Viral Hepatitis 2018; 25(2): 144 doi: 10.1111/jvh.12800
|